InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Yi Qingqing, 董事. Director active across 2 companies, notably BeiGene, Ltd.. In total, 11 reports have been published. Split: 0 buy · 1 sell. Total volume traded: €56k. Activity tracked since 16 June 2021. The latest transaction was disclosed on 1 June 2026 (Sale). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Yi Qingqing
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
487,708 股ShareXHKGHKEX:DA20260616E00364
10,985 股ShareXHKGHKEX:DA20260603E00327
3,055 股@ HK$21.470.0000% mcap11.3% 占其流量ShareXHKGHKEX:DA20260603E00334
235 股@ US$279.130.0002% mcap100.0% 占其流量American Depositary SharesSEC:0000919574-26-003800:0
29,614 股0Ordinary SharesSEC:0000902664-25-002711:0
10,985 股0Ordinary SharesSEC:0000902664-25-002529:0
16,341 股0Ordinary SharesSEC:0000902664-24-004124:0
12,922 股0Ordinary SharesSEC:0000902664-23-003641:0
7,800 股0Ordinary SharesSEC:0000902664-22-004101:0
16,692 股0Ordinary SharesSEC:0000902664-22-003398:0
7,800 股0Ordinary SharesSEC:0000902664-21-003255:0
11 条申报中的 11 条
About Yi Qingqing
Yi Qingqing is Administrateur at BeiGene, Ltd. and BeOne Medicines Ltd. He has 11 filings in total, and among the sampled recent filings, the transactions span 2021-06-24 to 2026-06-17, with 0 in purchases and 63670 in sales, and the modal transaction nature is Attribution.
